Advanced search
Publication Cover
Infection and Drug Resistance Volume 15, 2022 - Issue
Submit an article Journal homepage
180
Views
3
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

More Than Three-Fourths of AstraZeneca (ChAdox1 COV-19) COVID-19 Vaccinated Individuals Develop Post Immunization Adverse Event in Northwest Ethiopia

Atalay Goshu Muluneh1 Department of Epidemiology and Biostatistics, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, EthiopiaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-2556-4158View further author information
ORCID Icon,
Mehari Woldemariam Merid1 Department of Epidemiology and Biostatistics, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, EthiopiaView further author information
,
Kassahun Alemu Gelaye1 Department of Epidemiology and Biostatistics, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, EthiopiaORCID Iconhttps://orcid.org/0000-0003-4647-5178View further author information
ORCID Icon,
Sewbesew Yitayih Tilahun2 Department of Psychiatry, School of Medicine, College of Medicine and Health Sciences, University of Gondar, Gondar, EthiopiaView further author information
,
Nahom Worku Teshager3 Department of Pediatrics and Child health, School of Medicine, College of Medicine and Health Sciences, University of Gondar, Gondar, EthiopiaView further author information
,
Aklilu Yiheyis Abereha4 Department of Surgery, School of Medicine, College of Medicine and Health Sciences, University of Gondar, Gondar, EthiopiaView further author information
,
Kalkidan Samuel Sugamo5 Department of Internal medicine, School of Medicine, College of Medicine and Health Sciences, University of Gondar, Gondar, EthiopiaView further author information
,
Mulugeta Ayalew Yimer3 Department of Pediatrics and Child health, School of Medicine, College of Medicine and Health Sciences, University of Gondar, Gondar, EthiopiaORCID Iconhttps://orcid.org/0000-0003-3089-2567View further author information
ORCID Icon &
Getahun Molla Kassa1 Department of Epidemiology and Biostatistics, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, EthiopiaORCID Iconhttps://orcid.org/0000-0002-9926-7797View further author information
ORCID Icon show all
Pages 2409-2416 | Published online: 03 May 2022

Figures & data

Figure 1 Type and frequency of adverse events developed following ChAdOx1 COVID-19 immunization among medical and health care professionals in University of Gondar (n=263).

Figure 1 Type and frequency of adverse events developed following ChAdOx1 COVID-19 immunization among medical and health care professionals in University of Gondar (n=263).

Figure 2 (A) Number of days the study participants developed AEFI and (B) number of days the AEFI symptom takes to resolve.

Figure 2 (A) Number of days the study participants developed AEFI and (B) number of days the AEFI symptom takes to resolve.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.